Toda Drugdiag® 3 THC

Addictive Substances

Rapid semi-quantitative screening test for THC in urine

Immunochromatographic dipstick test for detecting THC (cannabis) levels in urine at three thresholds, to enable appropriate and nuanced care.

The test is based on a competitive method that identifies specific antibodies.

Simple, rapid, and precise urine screening

Advantages of Toda Drugdiag® 3THC

RAPID

The test is performed in less than one minute and results are obtained in 5 minutes.

PRECISE

Detects three concentration levels of THC for a more precise and nuanced reading.

EASY TO USE

Dip test: no pipette is required. Easy-to-read results.

Drugs in the workplace: why is screening an essential safety lever ?

+107%

c’est l’augmentation alarmante des tests positifs à l’alcool ou aux stupéfiants en entreprise sur une période de huit ans ( entre 2017 et avril 2025).

Source : Article « Drogues au travail : la consommation d’alcool et de stupéfiants s’envole », publié par Santé Mentale (13 juin 2025).

20 to 30%

des accidents du travail impliquent la consommation de drogues, d’alcool, de tabac ou de médicaments psychotropes.

Source : Fiche pratique « Prévention des conduites addictives en milieu professionnel », publiée par la DREETS Auvergne-Rhône-Alpes (23 décembre 2021).

Plus de 31%

c’est la proportion de salariés qui consomment du cannabis (tous âges confondus selon les études de panels spécifiques citées).

Source : Rapport « Consommation de drogues illicites en milieu professionnel : état des lieux des connaissances et des recherches menées en France », publié par l’Observatoire français des drogues et des tendances addictives [OFDT] (Août 2023).

Table of detected drugs

Consult the list of detected substances and their respective detection thresholds below.

Product Name
References
Drugs detected, detection threshold: ng/mL
Cannabis (THC)
Toda Drugdiag® 3THC
1041-3THC
20 50 150
Toda Drugdiag® 3THC+
1041-3THC+
50 150 300

The Toda Drugdiag 3 THC and 3 THC+ are differentiated by their detection thresholds. The 3 THC represents a traditional model, suitable for a wide range of screening situations, whereas the 3 THC+ is intended for users with higher consumption levels.

Contact us!

Require additional information?

Additional thresholds or specific parameters can be provided upon request. Our team remains available to assist you and answer your questions.

An accurate test starts with proper technique

Discover in 3 simple steps how to use the Toda Drugdiag® 3THC. 

This test is intended for use by healthcare professionals only.

Practical information

All boxes contain: 

The test should be stored at room temperature (between 2°F and 104°F).

Helpful documents

Product catalogs & data sheets

Catalog of addictive substances

Toda Drugdiag Product Sheet® 3 THC

For any additional information requests

"*" indicates required fields

Last Name*
Email*
Do you have a question or a specific need? Our team is here to help.

Learn more

1. Why is it important to screen for cannabis use?

Cannabis screening via a dip-card urine test is an essential tool for detecting the presence of THC, even when the immediate effects of consumption have subsided. THC, the primary psychoactive compound in cannabis, can remain detectable in urine for several days or even weeks, depending on the frequency of use.

This type of test enables: 

Criteria Saliva Test Urine Test
Sample Type
Saliva
Icône - Salive
Urine
Icône - Salive
Invasiveness
Non-invasive
no privacy required
More intrusive
sometimes requires supervision
Detection Window
6 to 12 hours depending on the drug type,
(Recent consumption)
2 to 10 days
(Past or chronic use)
Substances Detected
Substances Detected
Active Drug
(Current effect)
Metabolites
(Residues after consumption)
Risk of Falsification
Risk of Falsification
Low
(Easy supervision)
Higher
(Dilution, sample substitution)
Context of Use
Context of Use
Businesses, occupational health, police
(Ideal for mobile use)
Occupational health, hospitals, laboratories
(Requires a secure environment)

The detection window for cannabis in the body varies depending on several factors:

  • The quantity consumed,
  • The frequency of use (occasional or regular),
  • The individual's metabolism,
  • As well as the type of test utilized.

With a urine test, THC is generally detectable 3 to 7 days after use in an occasional user, and up to 2 to 4 weeks (sometimes longer) in a regular user, due to its accumulation in fat tissue.

Detection in urine is therefore longer than in saliva, making it a suitable solution for monitoring or screening.

The Toda Drug Diag 3 THC enables the detection of three levels of THC concentration in urine, unlike conventional tests which offer only a single threshold. This provides a more precise interpretation of the result.

A low threshold may indicate recent or occasional use, whereas a higher threshold often corresponds to more significant or repeated usage.

This distinction aids in a more accurate interpretation of results, particularly within the context of monitoring or prevention initiatives.

  • Adhere to pre-collection instructions

For a urine test, it is advisable to avoid excessive water consumption before collection to prevent sample dilution and skewed results. Similarly, it is important to collect a midstream urine sample, meaning after urination has commenced, to avoid contamination. 

  • Select a clean and appropriate environment

Urine must be collected in the container provided with the test kit. This prevents any alteration of the sample. The container must be handled carefully, without direct hand contact, to preserve sample quality. In a professional setting, it is recommended that sample collection be supervised by a trained individual, ensuring adherence to the procedure and confidentiality.

  • Respect the confidentiality and dignity of the tested individual

Screening must be conducted with respect for individual rights, preserving dignity and privacy. This specifically means avoiding any form of stigmatization or humiliation during sample collection. Adherence to these principles fosters cooperation and reduces stress for the tested individual, which can indirectly influence sample quality.

  • Ensure traceability and identification

Identify each test (name, date, time, batch number) to guarantee complete traceability, particularly in professional, medical, or legal settings.

  • Anticipate potential interferences

Certain medications or health conditions (e.g., dry mouth, treatments) can alter results. Verify the individual's health status and recent substance consumption before the test.

Complementary diagnostics in this range

Need information, training, or a quote?

Tell us what you are looking for, and we will promptly provide a tailored solution.

Back to Top